A detailed history of Carmignac Gestion transactions in Elevance Health, Inc. stock. As of the latest transaction made, Carmignac Gestion holds 314,576 shares of ELV stock, worth $124 Million. This represents 2.81% of its overall portfolio holdings.

Number of Shares
314,576
Previous 122,426 156.95%
Holding current value
$124 Million
Previous $66.3 Million 146.59%
% of portfolio
2.81%
Previous 1.16%

Shares

22 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2024

Nov 13, 2024

BUY
$500.12 - $562.29 $96.1 Million - $108 Million
192,150 Added 156.95%
314,576 $164 Million
Q2 2024

Aug 13, 2024

BUY
$497.49 - $547.8 $60.9 Million - $67.1 Million
122,426 New
122,426 $66.3 Million
Q2 2023

Aug 11, 2023

SELL
$436.33 - $496.2 $115 Million - $131 Million
-264,698 Reduced 85.84%
43,665 $19.4 Million
Q1 2023

May 12, 2023

SELL
$446.3 - $502.2 $63 Million - $70.9 Million
-141,176 Reduced 31.4%
308,363 $142 Million
Q4 2022

Feb 13, 2023

SELL
$465.23 - $546.77 $13.8 Million - $16.2 Million
-29,585 Reduced 6.17%
449,539 $231 Million
Q3 2022

Nov 10, 2022

SELL
$445.98 - $507.0 $12 Million - $13.6 Million
-26,883 Reduced 5.31%
479,124 $218 Million
Q2 2022

Aug 12, 2022

SELL
$444.32 - $529.84 $44.6 Million - $53.2 Million
-100,321 Reduced 16.55%
506,007 $244 Million
Q1 2022

May 13, 2022

SELL
$428.44 - $502.48 $55.6 Million - $65.2 Million
-129,768 Reduced 17.63%
606,328 $298 Million
Q4 2021

Feb 11, 2022

SELL
$370.08 - $467.67 $20.4 Million - $25.7 Million
-55,054 Reduced 6.96%
736,096 $341 Million
Q3 2021

Nov 12, 2021

SELL
$357.51 - $398.13 $918,800 - $1.02 Million
-2,570 Reduced 0.32%
791,150 $295 Million
Q2 2021

Aug 13, 2021

SELL
$352.19 - $401.9 $44.7 Million - $51 Million
-126,914 Reduced 13.79%
793,720 $303 Million
Q1 2021

May 14, 2021

BUY
$287.7 - $371.31 $365,954 - $472,306
1,272 Added 0.14%
920,634 $330 Million
Q4 2020

Feb 12, 2021

BUY
$270.17 - $333.15 $29 Million - $35.7 Million
107,166 Added 13.19%
919,362 $295 Million
Q3 2020

Nov 13, 2020

SELL
$245.73 - $284.63 $565,916 - $655,502
-2,303 Reduced 0.28%
812,196 $218 Million
Q2 2020

Aug 13, 2020

BUY
$203.3 - $300.59 $6.7 Million - $9.91 Million
32,959 Added 4.22%
814,499 $214 Million
Q1 2020

May 14, 2020

SELL
$174.68 - $307.74 $39.6 Million - $69.8 Million
-226,775 Reduced 22.49%
781,540 $177 Million
Q4 2019

Feb 13, 2020

SELL
$234.82 - $306.42 $6.29 Million - $8.21 Million
-26,778 Reduced 2.59%
1,008,315 $305 Million
Q3 2019

Nov 13, 2019

BUY
$237.69 - $310.48 $2.33 Million - $3.05 Million
9,814 Added 0.96%
1,035,093 $249 Million
Q2 2019

Aug 13, 2019

SELL
$236.25 - $293.76 $35.2 Million - $43.8 Million
-149,186 Reduced 12.7%
1,025,279 $289 Million
Q1 2019

May 14, 2019

BUY
$248.42 - $317.42 $49 Million - $62.6 Million
197,289 Added 20.19%
1,174,465 $337 Million
Q4 2018

Feb 13, 2019

BUY
$249.0 - $296.25 $74.4 Million - $88.6 Million
298,943 Added 44.08%
977,176 $257 Million
Q3 2018

Nov 13, 2018

BUY
$238.27 - $274.12 $162 Million - $186 Million
678,233 New
678,233 $186 Million

Others Institutions Holding ELV

About Elevance Health, Inc.


  • Ticker ELV
  • Exchange NYSE
  • Sector Healthcare
  • Industry Healthcare Plans
  • Shares Outstandng 240,000,992
  • Market Cap $94.5B
  • Description
  • Elevance Health Inc. operates as a health benefits company. It supports consumers, families, and communities across the entire care journey connecting to the care, support, and resources to lead healthier lives. It serves approximately 118 million people through a portfolio of medical, digital, pharmacy, behavioral, clinical, and care solutions....
More about ELV
Track This Portfolio

Track Carmignac Gestion Portfolio

Follow Carmignac Gestion and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Carmignac Gestion, based on Form 13F filings with the SEC.

News

Stay updated on Carmignac Gestion with notifications on news.